Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by SamV21on Oct 18, 2021 3:42pm
109 Views
Post# 34019657

RE:RE:RE:RE:RE:Major short term milestones

RE:RE:RE:RE:RE:Major short term milestones CORRECTION REDUVO DIN UPDATE  , Heath Canada site says 6 months to 2 YEARS (JUNE 2023 ? maybe then  ) to obtain a DIN NUMBER you pumpers make it sound like you just fill out the form and order it on line and it is 100% shipped, order may not be filled , it might just go on the GUY wish list .
And remember REDUVO contains Dronabinol a narcotic,
I bet Health Canada is going to spend more time evaluating it because of that.

They keep changing the estimates initial was 80 Million by 2022 then most recent was 121 million over 5 years by 2026, I really don't think they have any idea and again remember these are gross amounts NOT NET. What ever  the amount is it will not be enough to pull Tetra out of the toilet or fund all these other dreams.So once again we are held in suspence till Feb. for an out come that might not change the financial position we are in, would be  like going to pick bottles to make a mortgage payment , it just is not enough to make that much of a difference. 
All the other items will not be anything for years and years , updates mean nothing , Phase 2,3,4 take years and years.Most get knocked off during phase 2.
Its all just pumping... All these milestones and the price is where it was 7 months ago, because the company has been divided up so much just to stay afloat, all these undisclosed deal amounts , spread so thin , is there going to be any profit at the end of the day ever ?  Shareholders have lost here bigtime while Guy keeps lining his pockets funding his dreams on our the shareholders money.I thought he had a team of experts that know how long this stuff takes and knew the ropes , seems like they are going day by day not knowing how long any thing takes . We didn't invest here for fun , while the rest of the market is up  at all time highs and here we sitting at 7 month ago prices we had in April .Here comes another raise and dilution.

PAID PUMPERS CAN"T READ THOUGH !

<< Previous
Bullboard Posts
Next >>